BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2646656)

  • 1. Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias.
    Kopelman HA; Horowitz LN
    Prog Cardiovasc Dis; 1989; 31(5):355-66. PubMed ID: 2646656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
    Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone in the nineties: to whom and what dosage?].
    Moro Serrano C; Hernández Madrid A; Lage Silveira J; Vivas Alvarez E; Kanjhi M
    Rev Esp Cardiol; 1995 Apr; 48(4):272-84. PubMed ID: 7740149
    [No Abstract]   [Full Text] [Related]  

  • 8. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
    Tuzcu EM; Gilbo J; Masterson M; Maloney JD
    Cleve Clin J Med; 1989 May; 56(3):238-42. PubMed ID: 2743545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP; Prystowsky EN; Heger JJ
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of amiodarone in tachyarrhythmias.
    Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten years of experience with amiodarone.
    Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
    Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
    Marcus FI; Fontaine GH; Frank R; Grosgogeat Y
    Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone: pharmacology and antiarrhythmic and adverse effects.
    Naccarelli GV; Rinkenberger RL; Dougherty AH; Giebel RA
    Pharmacotherapy; 1985; 5(6):298-313. PubMed ID: 2934688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.